• 1.

  Protection for Human Rights and Privacy of Patients
  No publication can be made in any form including the introduction of an article, photographs, family profile, etc., which discloses personal information that may reveal the identity of a patient. If disclosure of the patient's personal information is inevitable and is based on scientific value, explanation for disclosure to the patient and a consent form signed by either the patient, the parents, or the guardian for the to-be-publicized material must be received. The author must show the to-be-publicized material including photographs to the patient at the time for approval. In order to establish patient's anonymity, all unnecessary detailed personal information of the patient should be eliminated and cannot be changed or forged. In any circumstances where the patient's anonymity is challenged and there is a smallest risk of disclosure (for example, masking the eye section of a patient in a picture) a consent form must be received.

• 2.

  Ethics Statement
  In case of research with experiments on human subjects, the Committee shall review compliance with ethical standards of the Helsinki Declaration of 1975 (the revised edition of 2013) and those of local ethics committee or the institutional review board of clinical experiments. The research must secure advance approval of the Institutional Review Board and consent of the patient and put this fact in writing in the discussion of the article. Descriptive materials such as photographs must not show the patient’s name, English initials, or hospital ID number. In animal experiments, it must be written to show that it meets the institute or national regulation of experiment committee concerning breeding and use of experiment animals.

• 3.

  Authorship
  The journal follows the recommendations for authorship by the International Committee of Medical Journal Editors (ICMJE; http://www.icmje.org/recommendations/). All persons designated as authors must partially or completely fulfill all the following four conditions; they had contributed in 1) conception and design, or analysis and interpretation, 2) drafting the article or revising it critically for important intellectual content, 3) final approval of the version to be published, and 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Group members who do not meet these criteria for authorship should be listed, with their permission, in the ‘Acknowledgments’. Examples of activities that alone (without other contributions) do not qualify a contributor for authorship are acquisition of funding; general supervision of a research group or general administrative support; and writing assistance, technical editing, language editing, and proofreading.

• 4.

  Conflict-of-Interest Statement
  The author is responsible for disclosing any financial support or benefit that might affect the content of the manuscript or might cause a conflict of interest. Examples of potential conflicts of interest are financial support from or connections to pharmaceutical companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.

• 5.

  Managing Research and Publication Misconduct
  The journal will follow JHPC ethical policies and the guidelines by the Committee on Publication Ethics (COPE, http://publicationethics.org/) for settlement of any misconduct.

• 6.

  Originality and Duplicate Publication
  A paper that has already been reported in another journal or is a redundant material previously published will not be accepted. If the paper contains similar work that has already been reported in an another publication or has been published in the journal, the author should include copies of such material along with the submitted paper. The Editorial Committee of Journal of Hospice and Palliative Care will decide on the matter of republication of the submitted paper and then consider for its acceptance. Also, the author can not submit a published paper to an another journal without authorization. Only under the conditions of the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (ICMJE), this may be allowed.

• 1.

  Description of Gender
  Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex or gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.

• 2.

  Copyrights
  Once publication of the manuscript has been decided, the copyrights will be transferred the Korean Society for Hospice and Palliative Care, and the author should sign the required document. The Korean Society for Hospice and Palliative Care has the right to publish, distribute, and print the work in the journal or other media.

• 3.

  Open Access Policy
  This journal is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided that the original work is properly cited. Author(s) do not need to be permitted for use of tables or figures published in JHPC in other journals, books, or media for scholarly and educational purposes. This is in accordance with the Budapest Open Access Initiative definition of open access.

• 4.

  Publication Fees
  In principle, the journal does not charge authors for peer reviews or publication for all manuscripts if at least one main author (first author or corresponding author) subscribes to the journal. For manuscripts with non-member main authors only, 200,000 KRW should be charged for publication. Authors should agree to a mandatory overlength page charge (200,000 KRW per page and 400,000 KRW for color figures) for manuscripts that exceed the maximum word count or number of figures allowed by the editorial policy. The overlength page charge rates are subject to change according to inflation.

The types of manuscripts are limited to original articles, review articles, case reports, and brief communications. The manuscript must be written in English.

• 1.

  Original Articles
  The contents of the attached file should be prepared on a separate page in the order of (1) Title page, (2) Title and author, (3) Abstract and key words, (4) Introduction, (5) Methods, (6) Results, (7) Discussion, (8) Acknowledgements (if necessary), (9) References, (10) Funding resources and conflict of interest, (11) Tables, and (12) Figures. The length of manuscript is limited to 5,000 words (excluding title page, abstract, references, tables, figures, and any supplemental content). The total number of the figures and graphs in an article should not exceed seven.

• 2.

  Review Articles
  Review Articles and Editorials are usually solicited by the Editor-in-Chief. However, unsolicited Review Articles will also be considered for publication, in which case authors should submit their curriculum vitae in addition to the manuscript. (1) Title page, (2) Abstract and key words, (3) Introduction, (4) Text, (5) Results, (6) Acknowledgements (if necessary), (7) References, (8) Tables, and (9) Figures should be written in order each on a separate page.

• 3.

  Case Reports
  A case report describes a new case, care or technique in hospice and palliative care. Also, palliative grand round or seminar can be published in the form of case discussions in palliative medicine. They should be significant enough in view of hospice and palliative care and decision to accept the article shall be determined following the review of the editorial committee. (1) Title page, (2) Abstract and keywords, (3) Introduction, (4) Case presentation, (5) Discussion, (6) References, (7) Tables, and (8) Figures should be written in the above order of sequence. The length of the text excluding references, tables, and figures should not exceed 2,500 words.

• 4.

  Brief Communications
  Any researcher may write an opinion regarding particular topics of academic interest or critique of originality regarding recent articles featured in Journal of Hospice and Palliative Care. (1) Title page, (2) Abstract and key words, (3) Main text, (4) References, (5) Tables, and (7) Figures should be written in the above order of sequence. The length of the text excluding references, tables, and figures should not exceed 2,500 words. The number of tables and figures in total should not exceed more than two.

The manuscript should be written using the Windows program Microsoft Word (.doc) or Hangul (.hwp). ISO A4 sized paper (212×297 mm) should be used with a margin space on top, bottom, right and left of 25 mm or more. Title page, abstract, text, acknowledgement, references, tables, and figures should all be double-spaced. Marking the title page as page one, all other pages should be marked consecutively and files should be attached.

• 1.

  Title Page
  The title page should state the following in sequence. 1) Title, 2) Authors and their affiliation, 3) Financial support (if any), 4) Corresponding author (name, affiliation, e-mail, and ORCID number).
  The title page should be written in English, and should encapsulate the substance of the research in as few words as possible.

• 2.

  Author(s)
  If there are two or more authors, the order of authorship should be based upon the substantial contributions given to the research and drafting and a comma should be placed to separate the authors. If the name of the affiliation of the authors is different, it should follow the order of authorship with a comma to separate each author. The first author and authors of different affiliation should be differentiated using the mark ‘*, †, ‡, §, ∥, ¶, **’ accordingly on the name of the author as well as their affiliation. The corresponding author should be the revising author of the submitted manuscript and should be marked distinctly to the author in particular. The corresponding author along with the first author should take responsibility for the revision of the submitted manuscript under review. If there is no corresponding author designated, the editorial committee will acknowledge the first author as the corresponding author.
  For author names, ‘first name surname’ order should be used. The highest title degree of the author should be followed after the name separated by a comma.

• 3.

  Abstract and Key Words
  Abstract should follow the four sequence headings of Purpose, Methods, Results, and Conclusion. It should be written appropriately to convey the outline and should not exceed more than 250 words. Key words ranging from 3 to 10 words should be attached at the bottom of the abstract and checked to confirm that it is listed under the Medical Subject Headings (MeSH) of the U.S. National Library of Medicine. The abstract should not disclose the author's name, position, or affiliation.

• 4.

  Introduction
  State the purpose of the article and elaborate on its significance. Summarize the rationale and give strictly pertinent references only. Do not reiterate or list related topics diffusely and do not include data or conclusions from the work being reported.

• 5.

  Methods
  Identify the methods. Describe subjects, laboratory animals, or controls clearly and identify procedures in sufficient detail to allow other workers to reproduce the results. Especially, describe the methods that confirmed the diseases of research and the methods to control subjective bias. Identify the apparatus or reagents used by giving the name of the product, followed by the name of the product company in parentheses. Give references to established methods, including statistical methods. Provide references and brief descriptions for methods that have been published but are not well known or substantially modified, and give reasons for using them and evaluate their limitations.
  Statistical analysis methods or statistical models must be explained in detail so as to confirm the results of the article. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals).
  Confirmation of statistical hypotheses must present P value as a result and state clearly relevance of the methods or the reasoning applied in confirmation. In case of statistical analyses with the use of computerized statistical programs, such programs must be specified as well.

• 6.

  Results
  Present your results in logical sequence in the text, tables, and figures. Do not repeat in the text all data in the tables or figures, but describe important points and trends.

• 7.

  Discussion
  Emphasize the new and important aspects of the study and the conclusions that follow from them. Do not repeat in detail data or other material given in the Introduction or the Results section. Include the implications of the findings and their limitations, including implications for future research.
  Link the conclusions with the goals of the study by discussing and comparing the relevant results of other research data. Avoid unqualified statements and conclusions not completely supported by the data. State new hypotheses when warranted and recommendations, when appropriate, may be included.

• 8.

  Acknowledgements
  If necessary, persons who have contributed to the paper but whose contributions do not justify authorship may be named. Clearly state their contributing role for acknowledgement. For example, data collection, financial support, statistical analysis, analysis of experiment, personal assistances, and so forth. Authors should notify that their names will be in the Acknowledgement and are responsible for obtaining permission from persons acknowledged.

• 9.

  Conflict of Interest
  If any conflict of interest about the article exists, the authors should describe it.

• 10.

  Author Contributions
  An explicit statement describing each author’s contributions to the manuscript is required in the manuscript.
  Ex) Conception or design of the work: OOO, Data collection: OOO, Data analysis and interpretation: OOO, Drafting the article: OOO, Critical revision of the article: OOO, Final approval of the version to be published: OOO.

• 11.

  References
  References should be written in English. The number of the references for one article should not exceed 30. References should be numbered serially in the order of appearance in the text, with reference numbers in brackets ([xx]). If referring to more than two sequential references, list all numbers ([1,2], [1-3], or [1,3-5]).
  References should be listed on a separate sheet at the end of the article in the order of citation. Reference format should conform to the NLM style (The NLM Style Guide for Authors, Editors, and Publishers, 2nd edition, 2007. https://www.ncbi.nlm.nih.gov/books/NBK7256/). Journal abbreviations should also conform to the NLM style (https://www.ncbi.nlm.nih.gov/books/NBK7256/). List all authors when there are six or fewer; when there are seven or more, list six and add “et al”.

  • 1)

    Article in Journals
    Name of Author. Title of the article. Name of Journal Year; Volume: Beginning page-Ending page.
    
    ① Less than six authors
    Zaza C, Baine N. Cancer pain and psychosocial factors: a critical review of the literature. J Pain Symptom Manage 2002;24:526-42.
    
    ② More than seven authors
    Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994;30:1326-36.
    
    ③ Group author
    Diabetes Prevention Program Reserch Group. Hypertension, insulin and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40:679-86.
    
    ④ Volume with supplement
    Shen HM, Zhang QF. Risk assessment of nickel carcinogenicity and occupational lung cancer. Environ Health Perspect 1994;102 Suppl 1:275-82.
    
    ⑤ Issue with supplement
    Payne DK, Sullivan MD, Massie MJ. Women’s psychological reactions to breast cancer. Semin Oncol 1996:23(1 Suppl 2):89-97.
    
    ⑥ No author given
    Cancer in South Africa [editorial]. S Aft Med J 1994;84:15.
    
    

  • 2)

    Monographs
    Name of Author. Title of Book. (Edition). Publishing Locale:Publishing Company;Year. (p. beginning page-end page.)
    
    ① Personal author(s)
    Yarbro CH, Goodman M, Frogge MH. Cancer nursing: principles and practice. 6th ed. Sudbury, MA:Jones and Bartlett Publishers;2005.
    
    ② Chapter in a book
    Collins J. Symptom control in life-threatening illness. In: Doyle D, Hanks G, Cherny N, Calman K, eds. Oxford textbook of palliative medicine. 3rd ed. New York:Oxford University Press;2004. p. 789-98.
    
    ③ Conference proceedings
    Kimura J, Shibasaki H, editors. Recent advances in clinical neurophysiology. Proceedings of the 10th International Congress of EEMG and Clinical Neurophysiology;1995 Oct 15-19;Kyoto, Japan. Amsterdam:Elsevier;1996.
    
    ④ Dissertation
    Kaplan SJ. Post-hospital home health care: the elderly's access and utilization [dissertation]. St. Louis (MO):Washington Univ.;1995.
    
    ⑤ In press
    Leshner AI. Molecular mechanisms of cocaine addiction. N Engl J Med. In press 1997.
    
    ⑥ Internet-based journal article (e-journal)
    Kaul S, Diamond GA. Good enough: a primer on the analysis and interpretation of noninferiority trials.
    Ann Intern Med [Internet]. 2006;145:62-9 [cited 2008 Jan 4]. Available from: http://www.annals.org/cgi/reprint/145/1/62.pdf.
    
    ⑦ Internet-based book (e-book)
    Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions [Internet]. Version 4.2.6. Chichester (UK):John Wiley & Sons, Ltd.;2006 [updated 2006 Sep]. Chapter 3, Guide to the contents of a protocol and review; [cited 2006 Nov 17];p. 37-57. Available from: https://training.cochrane.org/handbook/current.
    
    ⑧ Internet-based articles (home page)
    AMA: helping doctors help patients [Internet]. Chicago: American Medical Association;c1995-2007. [cited 2008 Feb 22]. Available from: http://www.ama-assn.org.
    familydoctor.org [Internet]. Leawood (KS): American Academy of Family Physicians; c2007 [cited 2008 Feb 20]. Available from: http://familydoctor.org.
    
    ⑨ Internet-based articles (books and similar references)
    Fact sheet: AIDS information resources [Internet]. Bethesda (MD):National Library of Medicine (US);2003. May 2 [updated 2007 Feb 20; cited 2007 Mar 26]. Available from: https://pubmed.ncbi.nlm.nih.gov/3361243/.
    
    

• 12.

  Tables
  The title and contents of tables should be written in English. And Tables should be uniformly displayed in concise and clear manner. It should be self-explanatory without the need to read the text. Type or print out each table with double spacing on a separate sheet of paper. If an abbreviation is used in each table or further explanation is necessary, place explanatory matter in footnotes. At the top right hand corner, place a symbol (*, †, ‡, §, ∥, ¶, ** in this sequence) that needs elaboration and explain in footnotes under each table for symbols marked. Capitalize the first letter of first word for each column. Capitalize P for P value.
  List the title of each table at the center on top. The sequence number for each table should be marked in Arabic numerals after the ‘Table’ with a space in between followed by a period. Cite tables in the text as ‘Table’.
  Capitalize the first letter of the first word in each title followed by a period. Units used in each table should be labeled within each table boundary and not outside as much as possible. Symbols used to label units should not unnecessarily be capitalized.
  Show the average, standard deviation (mean±S.D.), and the number of subjects, and identify statistical measures applied in the footnote of each table. For a proportion, give its relevant number and proportion, and for a correlation coefficient, provide correlation coefficient values.

• 13.

  Figures
  The title and contents of figures should be written in English. Figures and photographs should be clear and of sufficient size that, when reduced for publication, each item will still be legible. Figures and photographs explanations should be given on a separate sheet of paper. Figure explanations should not be limited to listing a title, but should provide detailed description. Figures should be numbered consecutively in Arabic numerals with a space after ‘Figure’ and followed by a period.
  Capitalize the first letter of the first word for title. On the back side of each figure, number them in pencil and mark top and bottom. When illustrating a figure, use a bar or a line graph for average or proportion, and list measures using standard deviation or standard error and must show their P values. Identify the applied statistical methods at the footnote of each figure.

• 14.

  Other Rules
  

  • 1)

    Use of Abbreviations
    Too frequent use of abbreviations is not allowed and should be limited to minimum.
    Use only standard abbreviations and do not use them on titles or abstracts. Unless it is a standard unit of measurement, the full term for which an abbreviation stands should precede its first use.

  • 2)

    Terms
    Academic terms should follow the standards described in the Scientific Technical Terminology Editions of Ministry of Education or the latest edition of the Medical Terminology of Korean Medical Association. If necessary, Chinese characters may be used in combination using parentheses. Drug names by principle should be printed in general names unless it is intended for a particular pharmaceutical product.

  • 3)

    Generic Names, Numbers, and Units
    Personal, geographical, and generic names should be used as original. And numbers expressed in Arabic numerals. Measuring units for length, height, weight, and volume should follow the decimal system of metric weights and measures (meters, grams, liters, etc.). Temperature should be in Celsius and blood pressure in mmHg. Units for blood and clinical laboratory test measurements should be expressed in the ordinary scale or by International Units (SI).

• 1.

  Submission
  All manuscripts should be submitted to e-submission system (http://www.e-jhpc.org/submission). Any other route of submission, e-mail for example, will not be accepted. The submitted article file (.hwp, .doc) must not contain personal information about the authors. Figures and graphs may be included either in the article file or be submitted separately. Author's checklist and consentment for copyright transfer must be submitted together with the original article. If the submitted article does not meet with the requirements of the submission regulation, revision may be recommended by the Academy, or publication of the article will be postponed otherwise.

• 2.

  Peer Review Process
  All manuscripts are peer reviewed by at least two specialists in the related fields. Acceptance of the manuscript shall be determined by the publication committee based on the review results. The articles postponed for publication pending revision must be resubmitted within three months after notice of revision. If the revised article should not be submitted within three months without a justifiable reason, it may be rejected for publication by discretion of the Committee.
  · The journal uses a double-blind peer-review process: the reviewers do not know the identity of the authors, and vice versa.
  · The editorial committee has the right to revise the manuscript without the authors’ consent, unless the revision substantially affects the original content.
  · Any appeal against an editorial decision must be made within 2 weeks of the date of the decision letter. Authors who wish to appeal against a decision should contact the editor-in-chief, explaining in detail the reasons for the appeal. If consensus cannot be reached thereby, an appeal will be discussed at a full editorial meeting. The process of handling complaints and appeals follows the guidelines of COPE available from (https://publicationethics.org/appeals).

• 1.

  Final Version
  After the paper has been accepted for publication, the author(s) should submit the final version of the manuscript. The names and affiliations of the authors should be double-checked, and if the originally submitted image files were of poor resolution, higher resolution image files should be submitted at this time. Symbols (e.g., circles, triangles, squares), letters (e.g., words, abbreviations), and numbers should be large enough to be legible on reduction to the journal’s column widths. All symbols must be defined in the figure caption. If references, tables, or figures are moved, added, or deleted during the revision process, renumber them to reflect such changes so that all tables, references, and figures are cited in numeric order.

• 2.

  Manuscript Corrections
  Before publication, the manuscript editor will correct the manuscript such that it meets the standard publication format. The author(s) must respond within 48 hours when the manuscript editor contacts the corresponding author for revisions. If the response is delayed, the manuscript’s publication may be postponed to the next issue.

• 3.

  Proofs and Reprints
  The author(s) will receive the final version of the manuscript as a PDF file. Upon receipt, the author(s) must notify the editorial office (or printing office) of any errors found in the file within 48 hours. Any errors found after this time are the responsibility of the author(s) and will have to be corrected as an erratum.

• 4.

  Errata and Corrigenda
  To correct errors in published articles, the corresponding author should contact the journal’s editorial office with a detailed description of the proposed correction. Corrections that profoundly affect the interpretation or conclusions of the article will be reviewed by the editors. Corrections will be published as corrigenda (corrections of the author’s errors) or errata (corrections of the publisher’s errors) in a later issue of the journal.

*For the policies on the research and publication ethics not stated in this instructions, International standards for editors and authors (https://publicationethics.org/resources/resources-and-further-reading/international-standards-editors-and-authors) can be applied.